| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $103.3M | +16.1% |
| SG&A Expense | $31.0M | +6.8% |
| Operating Income | -$52.2M | +42.6% |
| Income Tax | $135K | +800.0% |
| Net Income | -$50.9M | +44.0% |
| EPS (Basic) | -$0.99 | +45.6% |
| EPS (Diluted) | -$0.99 | +45.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $150.6M | +57.6% |
| Current Assets | $197.2M | +3.4% |
| Total Assets | $212.6M | -15.9% |
| Current Liabilities | $23.6M | +24.7% |
| Total Liabilities | $29.4M | +1.9% |
| Stockholders' Equity | $183.1M | -18.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.9M | +65.4% |
| Capital Expenditures | $919K | +146.4% |
| Investing Cash Flow | $83.5M | +237.9% |
| Financing Cash Flow | $442K | -99.5% |
| Free Cash Flow | -$29.8M | +64.5% |